Charles W. Lugar

616 total citations
14 papers, 523 citations indexed

About

Charles W. Lugar is a scholar working on Genetics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Charles W. Lugar has authored 14 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Charles W. Lugar's work include Estrogen and related hormone effects (8 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (2 papers). Charles W. Lugar is often cited by papers focused on Estrogen and related hormone effects (8 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (2 papers). Charles W. Lugar collaborates with scholars based in United States. Charles W. Lugar's co-authors include Jeffrey A. Dodge, Andrew L. Glasebrook, Henry U. Bryant, Lorri L. Short, Michael J. Martin, Thomas J. Bleisch, David E. Magee, Mary D. Adrian, Venkatesh Krishnan and Timothy I. Richardson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Tetrahedron Letters.

In The Last Decade

Charles W. Lugar

14 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles W. Lugar United States 11 234 221 175 69 63 14 523
Jacques Gilbert France 12 154 0.7× 147 0.7× 147 0.8× 32 0.5× 63 1.0× 17 420
Zhang B. Xu United States 7 455 1.9× 309 1.4× 231 1.3× 54 0.8× 175 2.8× 7 789
Michael D. Collini Canada 8 261 1.1× 267 1.2× 194 1.1× 52 0.8× 78 1.2× 10 571
Candido Gude United States 12 82 0.4× 487 2.2× 196 1.1× 67 1.0× 50 0.8× 24 670
Harvey N. Myers United States 6 212 0.9× 115 0.5× 144 0.8× 57 0.8× 28 0.4× 6 387
Toshie Fujishima Japan 19 548 2.3× 329 1.5× 215 1.2× 20 0.3× 65 1.0× 49 1.1k
Charles D. Jones United States 12 423 1.8× 364 1.6× 230 1.3× 121 1.8× 66 1.0× 14 861
M. LANG Switzerland 7 201 0.9× 91 0.4× 94 0.5× 35 0.5× 26 0.4× 12 417
Xiang‐Rong Jiang United States 8 149 0.6× 52 0.2× 115 0.7× 23 0.3× 48 0.8× 13 358
Donald W. Combs United States 17 94 0.4× 521 2.4× 244 1.4× 86 1.2× 20 0.3× 32 706

Countries citing papers authored by Charles W. Lugar

Since Specialization
Citations

This map shows the geographic impact of Charles W. Lugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Lugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Lugar more than expected).

Fields of papers citing papers by Charles W. Lugar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Lugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Lugar. The network helps show where Charles W. Lugar may publish in the future.

Co-authorship network of co-authors of Charles W. Lugar

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Lugar. A scholar is included among the top collaborators of Charles W. Lugar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Lugar. Charles W. Lugar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Richardson, Timothy I., Kuo‐Long Yu, Ying K. Yee, et al.. (2010). Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine Fibroids. ACS Medicinal Chemistry Letters. 2(2). 148–153. 46 indexed citations
2.
Richardson, Timothy I., Bryan H. Norman, Charles W. Lugar, et al.. (2007). Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 2: Structure–activity relationship studies on the benzopyran scaffold. Bioorganic & Medicinal Chemistry Letters. 17(13). 3570–3574. 30 indexed citations
3.
Norman, Bryan H., Jeffrey A. Dodge, Timothy I. Richardson, et al.. (2006). Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia. Journal of Medicinal Chemistry. 49(21). 6155–6157. 85 indexed citations
4.
Lugar, Charles W., Michael P. Clay, Terry D. Lindstrom, et al.. (2004). Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats. Bioorganic & Medicinal Chemistry Letters. 14(23). 5873–5876. 16 indexed citations
5.
Lugar, Charles W., David E. Magee, Mary D. Adrian, et al.. (2003). B-Ring unsaturated estrogens: biological evaluation of 17α-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens. Bioorganic & Medicinal Chemistry Letters. 13(24). 4281–4284. 10 indexed citations
6.
Kennedy, Joseph H., et al.. (2000). Development of analytical and preparative chromatographic separations of novel growth hormone secretagogue compounds. Journal of Chromatography A. 872(1-2). 75–84. 4 indexed citations
7.
Grese, Timothy A., Alexander G. Godfrey, Charles D. Jones, et al.. (1997). Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene. Journal of Medicinal Chemistry. 40(2). 146–167. 152 indexed citations
8.
Dodge, Jeffrey A., et al.. (1997). Synthesis and estrogen receptor binding affinities of the major human metabolites of raloxifene (LY139481). Bioorganic & Medicinal Chemistry Letters. 7(8). 993–996. 11 indexed citations
9.
O’Donnell, Martin, et al.. (1997). Solid-phase synthesis of unnatural amino acids using unactivated alkyl halides. Tetrahedron Letters. 38(41). 7163–7166. 25 indexed citations
10.
Dodge, Jeffrey A., Charles W. Lugar, Lorri L. Short, et al.. (1997). Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity. The Journal of Steroid Biochemistry and Molecular Biology. 61(1-2). 97–106. 47 indexed citations
11.
12.
Dodge, Jeffrey A. & Charles W. Lugar. (1996). Alcohol inversion of 17β-steroids. Bioorganic & Medicinal Chemistry Letters. 6(1). 1–2. 31 indexed citations
13.
14.
Ornstein, Paul L., M. Brian Arnold, Thomas J. Bleisch, et al.. (1996). Structure−Activity Studies of 6-(Tetrazolylalkyl)-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 1. Effects of Stereochemistry, Chain Length, and Chain Substitution. Journal of Medicinal Chemistry. 39(11). 2219–2231. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Gilbert Breakdown of academic impact, for papers by Zhang B. Xu Breakdown of academic impact, for papers by Michael D. Collini Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by Harvey N. Myers Breakdown of academic impact, for papers by Toshie Fujishima Breakdown of academic impact, for papers by Charles D. Jones Breakdown of academic impact, for papers by M. LANG Breakdown of academic impact, for papers by Xiang‐Rong Jiang Breakdown of academic impact, for papers by Donald W. Combs
Rankless by CCL
2026